Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma

Hua Dong1, Li Luo, Shengjun Hong

  • 1State Key Laboratory of Genetic Engineering and MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200433, China.

BMC Systems Biology
|December 1, 2010
PubMed
Abstract

Insights

This study integrates genetic mutations, gene expression, and microRNA networks to understand glioblastoma development. New methods reveal key pathways connecting these factors to glioblastoma initiation and progression.

Area of Science:

  • Genomics and Molecular Biology
  • Cancer Research
  • Neuro-oncology

Background:

  • Glioblastoma (GBM) pathogenesis involves complex genetic and environmental interactions.
  • Limited understanding exists on how genetic variations, gene expression, and microRNA (miRNA) expression integrate into regulatory networks driving GBM phenotypes.

Purpose of the Study:

  • To investigate the integrated network of genetic alterations, gene expression, and miRNA expression in glioblastoma.
  • To identify novel genes and miRNAs associated with glioblastoma and patient survival.
  • To develop methods for deciphering the pathways connecting molecular alterations to glioblastoma.

Main Methods:

  • Somatic mutation and loss of heterozygosity (LOH) analysis.
  • Gene and miRNA coexpression network construction.
  • Pathway enrichment analysis.
  • Development of novel methods for integrated multi-dimensional data analysis, including expression quantitative trait loci (eQTL) analysis.

Main Results:

  • Identified associations of somatic mutations in 14 genes (8 novel) and LOH in 11 genes (9 novel) with glioblastoma.
  • Constructed gene coexpression networks identifying 15 essential genes and miRNA networks identifying 19 key miRNAs, with 3 significantly impacting glioblastoma patient survival.
  • Discovered 3,953 predicted miRNA-mRNA pairs (14 experimentally verified) and identified significant enrichment in cancer-related pathways, synaptic transmission, and nervous system processes.
  • Developed novel methods to link mutations and expression data, identifying numerous cis- and trans-eQTLs for both somatic mutations and LOH, including miRNA-eQTLs.

Conclusions:

  • Integrated analysis of multi-dimensional data is crucial for unraveling glioblastoma initiation and progression mechanisms.
  • The study identified novel genetic and miRNA players and elucidated key molecular pathways involved in glioblastoma.
  • The developed methodologies offer a framework for future research into complex cancer systems.